These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1828 related items for PubMed ID: 16344100

  • 1. Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.
    Richardson P.
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S9-15. PubMed ID: 16344100
    [Abstract] [Full Text] [Related]

  • 2. Lenalidomide: an update on evidence from clinical trials.
    Dimopoulos MA, Terpos E.
    Blood Rev; 2010 Nov; 24 Suppl 1():S21-6. PubMed ID: 21126633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X, Aulagner G, Facon T.
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [Abstract] [Full Text] [Related]

  • 7. Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
    Sonneveld P, Hajek R, Nagler A, Spencer A, Bladé J, Robak T, Zhuang SH, Harousseau JL, Orlowski RZ, DOXIL-MMY-3001 Study Investigators.
    Cancer; 2008 Apr 01; 112(7):1529-37. PubMed ID: 18300257
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lenalidomide in multiple myeloma.
    Thomas SK, Richards TA, Weber DM.
    Best Pract Res Clin Haematol; 2007 Dec 01; 20(4):717-35. PubMed ID: 18070715
    [Abstract] [Full Text] [Related]

  • 10. Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
    Hazarika M, Rock E, Williams G, Dagher R, Sridhara R, Booth B, Farrell A, Justice R, Pazdur R.
    Oncologist; 2008 Oct 01; 13(10):1120-7. PubMed ID: 18922829
    [Abstract] [Full Text] [Related]

  • 11. Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.
    Klein U, Neben K, Hielscher T, Heiss C, Ho AD, Goldschmidt H.
    Ann Hematol; 2011 Apr 01; 90(4):429-39. PubMed ID: 20857112
    [Abstract] [Full Text] [Related]

  • 12. Treatment of relapsed/refractory multiple myeloma.
    Kastritis E, Palumbo A, Dimopoulos MA.
    Semin Hematol; 2009 Apr 01; 46(2):143-57. PubMed ID: 19389498
    [Abstract] [Full Text] [Related]

  • 13. Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
    Palumbo A, Dimopoulos M, San Miguel J, Harousseau JL, Attal M, Hussein M, Knop S, Ludwig H, von Lilienfeld-Toal M, Sonneveld P.
    Blood Rev; 2009 Mar 01; 23(2):87-93. PubMed ID: 18774632
    [Abstract] [Full Text] [Related]

  • 14. Lenalidomide in multiple myeloma.
    Richardson PG, Mitsiades C, Hideshima T, Anderson KC.
    Expert Rev Anticancer Ther; 2006 Aug 01; 6(8):1165-73. PubMed ID: 16925483
    [Abstract] [Full Text] [Related]

  • 15. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.
    Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2006 Jan 20; 24(3):431-6. PubMed ID: 16365178
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.